Department of Microbiology

Kwon, B. E., Ahn, J. H., Park, E. K., Jeong, H., Lee, H. J., Jung, Y. J., Shin, S. J., Jeong, H. S., Yoo, J. S., Shin, E., Yeo, S. G., Chang, S. Y. & Ko, H. J., 2019 Jan 1, In : Frontiers in Immunology. 10, OCT, 2542.

Research output: Contribution to journal › Article

Open Access

Galactosylceramides

Vaccinia virus

B-Lymphocytes

Vaccines

Immunization

Common variants in the glycerol kinase gene reduce tuberculosis drug efficacy

Bellerose, M. M., Baek, S. H., Huang, C. C., Moss, C. E., Koh, E. I., Proulx, M. K., Smith, C. M., Baker, R. E., Lee, J. S., Eum, S., Shin, S. J., Cho, S. N., Murray, M. & Sassetti, C. M., 2019 Jul 1, In : mBio. 10, 4, e00663-19.

Research output: Contribution to journal › Article

Open Access

Glycerol Kinase

Tuberculosis

Mycobacterium tuberculosis

Pharmaceutical Preparations

Genes

1 Citation (Scopus)

Delamanid, linezolid, levofloxacin, and pyrazinamide for the treatment of patients with fluoroquinolone-sensitive multidrug-resistant tuberculosis (Treatment Shortening of MDR-TB Using Existing and New Drugs, MDR-END): Study protocol for a phase II/III, multicenter, randomized, open-label clinical trial

Lee, M., Mok, J., Kim, D. K., Shim, T. S., Koh, W. J., Jeon, D., Lee, T., Lee, S. H., Kim, J. S., Park, J. S., Lee, J. Y., Kim, S. Y., Lee, J. H., Jo, K. W., Jhun, B. W., Kang, Y. A., Ahn, J. H., Kim, C. K., Shin, S., Song, T. & 8 others, Shin, S. J., Kim, Y. R., Ahn, H., Hahn, S., Won, H. J., Jang, J. Y., Cho, S. N. & Yim, J. J., 2019 Jan 16, In : Trials. 20, 1, 57.

Research output: Contribution to journal › Article

Open Access

Linezolid

Pyrazinamide

Multidrug-Resistant Tuberculosis

Levofloxacin

Fluoroquinolones